1. Home
  2. TBLA vs AMPH Comparison

TBLA vs AMPH Comparison

Compare TBLA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$5.06

Market Cap

952.2M

Sector

Technology

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$17.67

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
AMPH
Founded
2007
1996
Country
United States
United States
Employees
2000
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
952.2M
971.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
TBLA
AMPH
Price
$5.06
$17.67
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$5.00
$28.38
AVG Volume (30 Days)
2.7M
569.1K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
$7.63
$6.90
Revenue Next Year
$5.25
$4.64
P/E Ratio
$42.36
$122.93
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$16.65
52 Week High
$5.26
$31.26

Technical Indicators

Market Signals
Indicator
TBLA
AMPH
Relative Strength Index (RSI) 76.56 37.84
Support Level $3.86 $17.03
Resistance Level $5.26 $24.16
Average True Range (ATR) 0.24 0.91
MACD 0.04 -0.50
Stochastic Oscillator 87.58 15.00

Price Performance

Historical Comparison
TBLA
AMPH

About TBLA Taboola.com Ltd.

Taboola is a performance-based native advertising network designed to improve click-through rates and increase monetizable events for advertisers while generating yield for publisher websites. Taboola competes with Google, Amazon, and other advertising networks that display stories and products on websites. The company was founded in 2007 in Israel. It acquired Connexity, a retail advertising network, in 2021, and entered a partnership with Yahoo in 2022, in which it acquired exclusive native advertising rights over Yahoo digital properties in exchange for a 25% equity stake in the company.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: